We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

230 hedge funds and large institutions have $1.73B invested in Dr. Reddy's Laboratories in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 92 increasing their positions, 73 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $733K

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 73

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

3% more funds holding

Funds holding: 223 → 230 (+7)

2% more capital invested

Capital invested by funds: $1.7B → $1.73B (+$37.4M)

2.23% less ownership

Funds ownership: 73.05% → 70.81% (-2.2%)

Holders
230
Holders Change
+7
Holders Change %
+3.14%
% of All Funds
3.31%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
29
Increased
92
Reduced
73
Closed
20
Calls
$1.91M
Puts
$733K
Net Calls
+$1.18M
Net Calls Change
-$648K

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$24M
2
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$18.2M
3
JP Morgan Chase
JP Morgan Chase
New York
+$16.3M
4
Millennium Management
Millennium Management
New York
+$13.6M
5
AIM
Aikya Investment Management
United Kingdom
+$10.5M

Top Sellers

1
BlackRock
BlackRock
New York
-$60.1M
2
Morgan Stanley
Morgan Stanley
New York
-$55.5M
3
Goldman Sachs
Goldman Sachs
New York
-$20.3M
4
Lazard Asset Management
Lazard Asset Management
New York
-$13.1M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
101
Prelude Capital Management
New York
$1.1M – – –
BCI
102
Brinker Capital Investments
Pennsylvania
$1.09M +$23.2K +1,590 +2%
OPS
103
Orion Portfolio Solutions
Nebraska
$1.09M +$23.2K +1,590 +2%
RWA
104
Redhawk Wealth Advisors
Minnesota
$1.08M +$1.08M +73,710 New
CS
105
Credit Suisse
Switzerland
$1.08M +$8.18K +560 +0.8%
QI
106
Qtron Investments
Massachusetts
$1.08M – – –
SFA
107
Sequoia Financial Advisors
Ohio
$1.07M +$16.9K +1,160 +2%
LAM
108
Lifestyle Asset Management
Texas
$1.06M -$59.4K -4,065 -5%
Franklin Resources
109
Franklin Resources
California
$1.01M +$1.01M +69,050 New
Two Sigma Advisers
110
Two Sigma Advisers
New York
$1.01M -$3.12M -213,500 -76%
BP
111
Ballentine Partners
Massachusetts
$982K +$195K +13,330 +25%
Janney Montgomery Scott
112
Janney Montgomery Scott
Pennsylvania
$925K +$53K +3,630 +6%
CIBC World Market
113
CIBC World Market
Ontario, Canada
$924K – – –
LCM
114
Logan Capital Management
Pennsylvania
$917K +$3.65K +250 +0.4%
AG
115
AIA Group
Hong Kong
$910K +$89.1K +6,100 +11%
PHAM
116
Portland Hill Asset Management
United Kingdom
$906K -$39.6K -2,715 -4%
QCM
117
Quantinno Capital Management
New York
$899K +$222K +15,175 +33%
State of Wisconsin Investment Board
118
State of Wisconsin Investment Board
Wisconsin
$893K – – –
WFI
119
West Family Investments
California
$848K +$9.86K +675 +1%
EOJOAM
120
E. Ohman J:or Asset Management
Sweden
$836K +$21.9K +1,500 +3%
LIM
121
Longfellow Investment Management
Massachusetts
$823K – – –
ACM
122
Aquatic Capital Management
Illinois
$822K +$445K +30,500 +120%
NAM
123
NorthCrest Asset Manangement
Minnesota
$821K +$22.6K +1,550 +3%
PA
124
Parallel Advisors
California
$803K +$324K +22,190 +68%
Rockefeller Capital Management
125
Rockefeller Capital Management
New York
$802K -$417K -28,590 -34%
3 4
5
6 7

RDY Hedge Fund Activity: Q1 2024 in Review

230 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2024, worth a combined $1.73B — up 2.2% from $1.7B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RDY positions and 20 closed out — a net gain of 9 holders — while 92 added to existing stakes and 73 trimmed.

The largest buyer was Bank of America, adding an estimated $24M. The largest seller was BlackRock, cutting an estimated $60.1M.

  • 230 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2024, up from 223 in Q4 2023.
  • Funds reported $1.73B of Dr. Reddy's Laboratories stock for Q1 2024, up 2.2% quarter-over-quarter.
  • 29 funds opened new Dr. Reddy's Laboratories positions in Q1 2024 and 20 closed out, a net change of +9 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2024 was Bank of America, an estimated $24M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2024 was BlackRock, an estimated $60.1M sold.

Based on aggregated 13F filings for Q1 2024.